GNSS vs NVDA
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
Genasys Inc. exhibits critical financial instability, highlighted by a weak Piotroski F-Score of 2/9 and a dangerous Debt/Equity ratio of 9.35. While the company is experiencing hyper-growth in revenue (145.90% YoY), this has not translated into operational efficiency or earnings reliability, as evidenced by 0/4 earnings beats in the last year. Severe liquidity constraints (Current Ratio 0.73, Quick Ratio 0.45) and a massive Price-to-Book ratio of 45.00 suggest the stock is priced on speculative growth rather than fundamental value. The combination of high leverage and consistent earnings misses creates a high-risk profile despite the optimistic analyst target price.
NVDA exhibits strong financial health with a Piotroski F-Score of 7/9, indicating robust operational efficiency and solvency. While the current price of $182.08 is significantly above the Graham Number ($26.71) and the growth-based intrinsic value ($144.55), the stock is fundamentally undervalued relative to its growth, as evidenced by a PEG ratio of 0.72 and a highly attractive Forward P/E of 16.38. The company's elite profitability margins (55.6% profit margin) and minimal debt (0.07 D/E) provide a massive cushion for volatility. Despite bearish insider sentiment and short-term technical weakness, the long-term growth trajectory remains exceptionally strong.
Compare Another Pair
Related Comparisons
GNSS vs NVDA: Head-to-Head Comparison
This page compares Genasys Inc. (GNSS) and NVIDIA Corporation (NVDA) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.